The First and Only Low-osmolar Iodinated Contrast Media Approved for Oral Use in Canada
Presented by GE HealthCare Earlier this year, GE HealthCare announced Health Canada’s approval of Omnipaque injection for Oral use, making it the first and only low-osmolar iodinated contrast media approved for oral use in Canada. Omnipaque injection for Oral Use is indicated in adults and pediatrics 1. CT is utilized in imaging of the GI
The First and Only Low-osmolar Iodinated Contrast Media Approved for Oral Use in Canada Read More »









